XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income $ 70,997 $ 68,851
Net income from discontinued operations 0 100
Net income from continuing operations 70,997 68,751
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 21,359 22,184
Amortization of debt issue costs 481 313
Provision for doubtful accounts 1,852 156
Share-based compensation 8,633 8,792
Deferred income taxes 1,409 1,995
Finance lease interest 31 32
Changes in operating assets and liabilities:    
Accounts receivable 46,652 (67,404)
Inventories (136,257) (118,349)
Prepaid expenses and other assets 39,178 (15,002)
Other non-current assets (1,772) (2,791)
Accounts payable (60,717) 67,535
Accrued expenses and other liabilities (16,780) (12,745)
Income taxes payable 4,426 862
Net cash used in operating activities (20,508) (45,671)
Cash flows from investing activities:    
Capital expenditures (6,549) (3,326)
Proceeds from the sale of discontinued operations 0 3,125
Net cash used in investing activities (6,549) (201)
Cash flows from financing activities:    
Borrowings on revolving credit, net of expenses 1,871,909 1,597,270
Repayments on revolving credit, net of expenses (1,848,554) (1,552,976)
Borrowings (repayments) on long-term debt, net 16,527 (5,968)
Repayments on finance lease obligation (612) (932)
Debt issuance costs (1,407) 0
Exercise of stock options 853 1,592
Taxes paid on settlement of equity awards (2,433) (2,729)
Common stock repurchased (10,718) (8,527)
Net cash provided by financing activities 25,565 27,730
Effect of exchange rate changes on cash and cash equivalents 879 (1,037)
Decrease in cash and cash equivalents (613) (19,179)
Cash and cash equivalents at beginning of period 37,987 62,718
Cash and cash equivalents at end of period $ 37,374 $ 43,539